Bayer Halts Sales of Anti-Bleeding Drug

By ANDREW BRIDGES, Associated Press Writer, Medicine & Health / Medications

A bottle of the drug Trasylol by German pharma company Bayer is seen in a hospital in Dusseldorf, western Germany, Feb. 7, 2007. Drug maker Bayer AG said Monday, Nov. 5, 2007, that it has halted the global marketing of its anti bleeding drug Trasylol after a Canadian clinical study last month found that it could be linked to a higher risk of death than other drugs. (AP Photo/Roberto Pfeil)

(AP) -- Bayer AG halted worldwide sales Monday of its anti-bleeding drug Trasylol at the request of U.S. and foreign health officials pending further analysis of a Canadian study that suggests it's linked to a 50 percent higher risk of death than the other drugs in the clinical trial.

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

ť Next Article in Medicine & Health - Medications: FDA orders Trasylol temporarily withdrawn

would you recommend this story?